As an academic health system, Tampa General Hospital offers a collaborative approach to all patient care with experts representing multiple specialties. Our multidisciplinary team includes renowned hematology-oncology specialists, physician scientists, nurses, and physician assistants. Additionally, CNS Lymphoma patients work directly with a care navigator to answer any questions they may have and ensure their experience is as seamless as possible.
Medical Leadership
 |
Eduardo Sotomayor, MD Dr. Sotomayor is the vice president, executive director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. |
 |
Ivan Borrello, MD Dr. Ivan M. Borrello is a hematologist oncologist and renowned physician-scientist who serves as Medical Director of the Myeloma, Bone Marrow Transplant (BMT) and Cell Therapies program within the TGH Cancer Institute. Fluent in English, Italian, Spanish and Portuguese, Dr. Borrello is recognized as a leader in the field of immunotherapy of hematologic malignancies (leukemias, lymphomas, multiple myeloma) as well as bone marrow and stem cell transplants. |
Providers
 |
Alan Kerr, MD Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in malignant hematology. Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident. In the same department, he followed his passion for teaching future medical professionals as an assistant professor from 2015 to 2016. Dr. Kerr received his medical degree from the University of Louisville School of Medicine and holds a PhD in biochemistry and molecular biology from the University of Louisville. Dr. Kerr is a site investigator for numerous active clinical trials, and his primary clinical interests is lymphomas. Well-versed in translational research and clinical research protocols, Dr. Kerr is credited with several publications, oral presentations and abstracts on a wide range of oncology topics. He is a diplomate of the American Board of Internal Medicine and a member of the American Society of Clinical Oncology and the American Society of Hematology. |
 |
Nikesh Shah, MD Dr. Nikesh Shah is a hematologist-oncologist at Tampa General Hospital who specializes in hematologic malignancies, including aggressive lymphomas and acute lymphoblastic leukemia (ALL). Prior to joining Tampa General, Dr. Shah served as a chief fellow for the hematology/oncology fellowship program at Moffitt Cancer Center and the University of South Florida in Tampa. He completed the J. Willis Hurst Internal Medicine Residency Program at Emory University School of Medicine in Atlanta after receiving his medical degree from the University of Miami Leonard M. Miller School of Medicine in Coral Gables, Fla. Dr. Shah is dedicated to developing close relationships with his patients and their families, providing them with a full understanding of each disease and determining the best personalized care for each patient. To accomplish that, Dr. Shah enjoys conducting clinical research to identify the most cutting-edge treatment options available and has been credited with several peer-reviewed publications, presentations, abstracts and book chapters in areas of his expertise. He is also an internal medicine resident mentor and has provided professional insight as a speaker at multiple Lymphoma Clinical Congress sessions. Dr. Shah has memberships with the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology and the Florida Medical Association. He speaks English and Gujarati. |
Support Team
 |
Brigett Brandjes, PA-C |
 |
Jessica Neil, APP |
 |
Samantha Roberts, MSN, APRN, FNP-BC |
 |
Waleska Gonzalez Phone: (813) 844-5047 |
 |
Laura Kate Miller Phone: (813) 844-3463 |
